Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R SoRelle

Showing results (91-100 of 207) with videos related to

Pageof 21
Sort By:
Circulation|February 24, 2001
Direct myocardial revascularization a "placebo effect," according to study chiefR SoRelle
Circulation|February 24, 2001
Head injuries linked to Alzheimer's diseaseR SoRelle
Circulation|August 31, 2001
Lung-volume reduction surgery poses significant mortality risks to the sickest patientsR SoRelle
Circulation|September 22, 2001
Two-thirds of Bush-approved stem-cell lines too immature for research, Thompson says; NIH access to some assuredR SoRelle
Circulation|May 13, 1998
The surgeon general: David Satcher, MD, PhDR SoRelle
Circulation|October 10, 1997
Fen-phen and risk of valvular diseaseR SoRelle
Circulation|January 4, 2001
Gene therapists promise renewed vigor in monitoring as field progressesR SoRelle
Circulation|March 21, 2001
Contaminated feed heightens "mad cow" fears in the United StatesR SoRelle
Circulation|January 11, 2000
Late-breaking trials at American Heart Association's Scientific Sessions 2000R SoRelle
Circulation|September 17, 1998
Vascular and lipid syndromes in selected HIV-infected patientsR SoRelle
Pageof 21

Showing results (91-100 of 207) with videos related to

Sort By:
Pageof 21
Circulation|February 24, 2001
Direct myocardial revascularization a "placebo effect," according to study chiefR SoRelle
Circulation|February 24, 2001
Head injuries linked to Alzheimer's diseaseR SoRelle
Circulation|August 31, 2001
Lung-volume reduction surgery poses significant mortality risks to the sickest patientsR SoRelle
Circulation|September 22, 2001
Two-thirds of Bush-approved stem-cell lines too immature for research, Thompson says; NIH access to some assuredR SoRelle
Circulation|May 13, 1998
The surgeon general: David Satcher, MD, PhDR SoRelle
Circulation|October 10, 1997
Fen-phen and risk of valvular diseaseR SoRelle
Circulation|January 4, 2001
Gene therapists promise renewed vigor in monitoring as field progressesR SoRelle
Circulation|March 21, 2001
Contaminated feed heightens "mad cow" fears in the United StatesR SoRelle
Circulation|January 11, 2000
Late-breaking trials at American Heart Association's Scientific Sessions 2000R SoRelle
Circulation|September 17, 1998
Vascular and lipid syndromes in selected HIV-infected patientsR SoRelle
Pageof 21